These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
115 related articles for article (PubMed ID: 21193326)
41. The Impella 2.5 L for percutaneous mechanical circulatory support in severe humoral allograft rejection. Beyer AT; Hui PY; Hauesslein E J Invasive Cardiol; 2010 Mar; 22(3):E37-9. PubMed ID: 20197587 [TBL] [Abstract][Full Text] [Related]
43. C4d-the witness of humoral rejection. de Gouveia RH; Vitorino E; Ramos S; Rebocho MJ; Queirós E Melo J; Martins AP; Moura ML Transplant Proc; 2009 Apr; 41(3):866-7. PubMed ID: 19376374 [TBL] [Abstract][Full Text] [Related]
44. Formation of the inflammasome during cardiac allograft rejection. Shah KB; Mauro AG; Flattery M; Toldo S; Abbate A Int J Cardiol; 2015 Dec; 201():328-30. PubMed ID: 26301674 [No Abstract] [Full Text] [Related]
45. Survey of North American pathologist practices regarding antibody-mediated rejection in cardiac transplant biopsies. Kucirka LM; Maleszewski JJ; Segev DL; Halushka MK Cardiovasc Pathol; 2011; 20(3):132-8. PubMed ID: 20418115 [TBL] [Abstract][Full Text] [Related]
46. Detection of cardiac myosin-specific autoimmunity in a model of chronic heart allograft rejection. Rolls HK; Kishimoto K; Illigens BM; Dong V; Sayegh MH; Benichou G; Fedoseyeva EV Transplant Proc; 2001; 33(7-8):3821-2. PubMed ID: 11750627 [No Abstract] [Full Text] [Related]
48. T-cell interactions with extracellular matrix proteins and endothelium in chronic renal allograft rejection. Korczak-Kowalska G; Nowaczyk M; Stepién-Sopniewska B; Morzycka-Michalik M; Mrowiec T; Wierzbicki P; Paczek L; Durlik M; Wyzgał J; Matysiak W; Górski A Transplant Proc; 1997; 29(1-2):1057-9. PubMed ID: 9123197 [No Abstract] [Full Text] [Related]
49. Identification of the antibody to vascular endothelial cells in patients undergoing cardiac transplantation. Brasile L; Zerbe T; Rabin B; Clarke J; Abrams A; Cerilli J Transplantation; 1985 Dec; 40(6):672-5. PubMed ID: 3907041 [TBL] [Abstract][Full Text] [Related]
50. Reconsideration of the mechanism of first-set vascularized allograft rejection: some concluding remarks. Bach FH Hum Immunol; 1990 Jun; 28(2):263-9. PubMed ID: 2190955 [No Abstract] [Full Text] [Related]
51. Acute vascular rejection is associated with up-regulation of vitronectin receptor (alphavbeta3), increased expression of tissue factor, and activation of the extracellular matrix metalloproteinase induction system. Yamani MH; Starling RC; Young JB; Cook D; Yu Y; Vince DG; McCarthy P; Ratliff NB J Heart Lung Transplant; 2002 Sep; 21(9):983-9. PubMed ID: 12231369 [TBL] [Abstract][Full Text] [Related]
52. The Role of the Endothelium during Antibody-Mediated Rejection: From Victim to Accomplice. Cross AR; Glotz D; Mooney N Front Immunol; 2018; 9():106. PubMed ID: 29434607 [TBL] [Abstract][Full Text] [Related]
53. [Heart transplantation. Pathology, clinical work-up and therapy]. Baba HA; Wohlschläger J; Stypmann J; Hiemann NE Pathologe; 2011 Mar; 32(2):95-103. PubMed ID: 21305380 [TBL] [Abstract][Full Text] [Related]
54. A rendezvous before rejection: where do T cells meet transplant antigens? Briscoe DM; Sayegh MH Nat Med; 2002 Mar; 8(3):220-2. PubMed ID: 11875489 [TBL] [Abstract][Full Text] [Related]
55. Acute and modified rejection of heterotopic canine cardiac allotransplants studied by serial needle biopsy. Leedham PW; Baum M; Cullum PA Thorax; 1971 Sep; 26(5):534-42. PubMed ID: 4943955 [TBL] [Abstract][Full Text] [Related]
56. Editorial: Transvenous biopsy of the heart. Lancet; 1974 May; 1(7862):849. PubMed ID: 4132797 [No Abstract] [Full Text] [Related]
57. Heart-reactive antibody: an index of cardiac rejection in human heart transplantation. Ellis RJ; Lillehei CW; Fischetti VA; Zabriskie JB Circulation; 1970 May; 41(5 Suppl):II91-7. PubMed ID: 4952946 [No Abstract] [Full Text] [Related]
58. Raman spectroscopy detects cardiac allograft rejection with molecular specificity. Chung YG; Tu Q; Cao D; Harada S; Eisen HJ; Chang C Clin Transl Sci; 2009 Jun; 2(3):206-10. PubMed ID: 20443894 [TBL] [Abstract][Full Text] [Related]
59. Cellular and humoral parameters for vascular damage in blood during cytomegalovirus infections. The TH; Kas-Deelen AM; de Maar EF; Driessen C; Harmsen MC; van Son WJ Transplant Proc; 2001; 33(1-2):1813. PubMed ID: 11267524 [No Abstract] [Full Text] [Related]